We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kromek Group Plc | KMK | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 6.05 | 08:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.05 | 6.05 | 6.05 | 6.05 | 6.05 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 30/5/2024 13:36 by z1co Contract momentum builds at KromekRadiation detection technology company continues to win contracts from the medical imaging and nuclear markets. It has takeover potential too January 30, 2024 by Simon Thompson First half cash loss narrows from £2.7mn to £0.1mn Analysts push through material profit upgrades Sedgefield-based Kromek (KMK:5.8p), a radiation detection technology company, expects to report record revenue and return to cash profitability in the 12 months to 30 April 2024. The directors’ confidence is not misplaced if this week’s interim results are anything to go by. In the six-month period, Kromek won £8mn of orders including a contract worth $1.4mn (£1.1mn) from a new original equipment manufacturers (OEM) customer, an established player in the medical imaging sector in Asia. Kromek will supply its cadmium zinc telluride (CZT)-based detector modules for use in the company’s next-generation single-photon emission CT (SPECT)-based medical imaging scanners, and has won another four medical imaging orders from existing clients in recent weeks. |
Posted at 29/5/2024 21:21 by 33mick Well there is the hopefully soon to be announced development conclusion with Analogic who intend to incorporate CZT tech into a number of future products.Then the big one a Tier one global, everyone assumes Philips who are around about now after 12 months R&D work by Kmk on the cusp of releasing Thier first CZT based photon counting next gen scanner, both likely to be 7 multi Year supply contacts, then there's the CZT based ultra low dose breast imaging project due for some news, with US partners, so a bit of + news coming I think |
Posted at 29/5/2024 15:10 by z1co You can deramp this as much as you want to but reality is KMK is growing it's revenue and will eventually become profitable.It's a damn sight better than the pile of garbage RGB that you own. |
Posted at 29/5/2024 14:12 by jaknife Z1CO,I don't expect you to understand the simplicity of how the numbers work, or how hopelessly irrelevant the comment "EBITDA ahead of expectations" is. As noted above KMK will need to raise cash before September. So let us simply note for posterity that you said "buy" at 7.25p whilst I called you a dimwit and pointed out that a discounted placing was needed. Then we can revisit this in a few months and discuss it in more detail. It's a shame that we didn't do that when we discussed FAB, GDR or QED. And BTW, FWIW ROQ is a complete and utter total POS, it exists simply to part idiots from their cash to support the lifestyles of the insiders. JakNife |
Posted at 29/5/2024 13:19 by jaknife Kromek is a pile of sh-one-t. Year in, year out it pulls the wool over the eyes of amateur retail punters with some flim-flam BS only to raise funds in a discounted placing at the last minute.This time they claim that they'll be EBIDTA positive. Whoop whoop but what about actual profits? Cavendish forecast EBITDA of £1.2m for the full-year (to April 2024), which translates to a P&L loss of £5.3m. And normally KMK's cash losses exceed their P&L losses because they capitalise material expenses directly to the balance sheet (£4.8m worth last year). KMK reported cash of £3.7m at the interim stage (Oct 2023) and should burn cash of about £5m to £6m. Hence cash will run out before year end (Oct 2024) and, specifically cash will run out before they intend to publish the finals in September! Expect a discounted placing well before the finals are published. JakNife |
Posted at 30/4/2024 03:29 by ark87 Remeber that KMK started at 51p 12 years ago and back then Basu stated"Arnab Basu, CEO, commented: "We are delighted with our oversubscribed fundraising. After many years developing the business and our technology, Kromek is ready to begin harvesting value by seizing the opportunities to sell our technology and products into the medical imaging, security screening and nuclear detection markets." What went so wrong and how has Basu kept his job and such a nice wage? Wheres the accountability? |
Posted at 26/4/2024 04:08 by b00mb0y Yes. I agree. But a long way to go, yet, for my breakeven. Come on KMK! |
Posted at 25/4/2024 08:36 by citys2874 FABULOUS CONTRACT WIN TODAY FOR KMK AND STG .....NICE |
Posted at 09/3/2024 07:49 by croasdalelfc Polymer had 57m when the new loan was announced - now they have 84m which is the rest of the shares from CLNPolymer now has a material interest with 84m with 13% and are owed £5.5m by KMK |
Posted at 09/9/2023 22:26 by 33mick To put things in context and the short term (which it is )financing arrangements being hopefully sorted soon.Philips is a £4+ billion company that has been designing state of the art hi tech medical equipment and systems for longer than anyone's been alive reading this, if you look you will see Philips name has cropped up numerous times in Kmk past news releases and broker reports, they were working with kmk's US subsidiary EV Products who they took over 10 years ago. Analogic Corp a US privately owned company was sold 6 years ago for 1.1 bill dollars with est 500+ mil dollar annual revenues. Spectrum Dynamics the the first OEM to fully adopt Kmk's CZT into thier premier CT product are est to be valued at 50-100 mil dol. Plus the un-named new Asian 1.4 mil CZT SPECT imaging customer announced in May this year... these companies owners, CEO's, management ,design and development teams have thier money, reputations and future growth & profitability all firmly aligned and committed to using kmk's CZT gamma modules after years of collaboration in most cases. and I have no reason to doubt kmk's confident statements predicting the likes of Fuji medical, United Imaging and the others they are working with will not follow suit. But obviously AQC knows better! and presumably thinks all these bods have made a disastrous error of judgement. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
